Related Experiment Videos
Risk factors for the spread of antibiotic-resistant bacteria
1Department of Microbiology, University Hospital, Lewisham, London, England.
Abstract:
The emergence of antibiotic resistance is primarily due to excessive and often unnecessary use of antibiotics in humans and animals. Risk factors for the spread of resistant bacteria in hospitals and the community can be summarised as over-crowding, lapses in hygiene or poor infection control practices. Increasing antibiotic resistance in bacteria has been exacerbated by the slow pace in developing newer antibiotics. Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and multiresistant Gram-negative bacteria are spread primarily by direct or indirect person-to-person contact. Independent risk factors for MRSA include the use of broad spectrum antibiotics, the presence of decubitus ulcers and prosthetic devices while those for VRE include prolonged hospitalisation and treatment with glycopeptides or broad spectrum antibiotics. For the spread of resistant Gram-negative bacteria risk factors include urinary catheterisation, excessive use of antibiotics and contamination of humidifiers and nebulisers. The spread of penicillin-resistant pneumococci (PRP) and drug-resistant and multidrug-resistant tuberculosis (MDRTb) is due to airborne transmission. Risk factors for the spread of PRP include overcrowding, tracheostomies and excessive use of penicillins for viral respiratory infections; for MDRTb they include poor compliance, convergence of immunosuppressed patients, delayed diagnosis or treatment, and poor or inadequate ventilation and isolation facilities. Recent developments in the genomic mapping of many bacteria and advances in combinatorial chemistry promise to usher in a new era of antibiotic development. While this may result in our regaining some of the ground lost to resistant bacteria, there will still be a continuing need to minimise the spread of antibiotic resistance through the rational use of antibiotic agents and stringent infection control practice.
Insights
Antibiotic resistance is rising due to overuse and poor infection control. New drug development offers hope, but rational antibiotic use and strict hygiene are crucial to combat resistant bacteria like MRSA and VRE.
Area of Science:
- Microbiology and Infectious Diseases
- Public Health
- Pharmacology
Background:
- Antibiotic resistance is a growing global health threat, driven by excessive antibiotic use in humans and animals.
- Factors like overcrowding, poor hygiene, and slow development of new antibiotics exacerbate the spread of resistant bacteria.
- Specific resistant pathogens, including Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant enterococci (VRE), and multidrug-resistant Gram-negative bacteria, pose significant challenges.
Purpose of the Study:
- To summarize the primary causes and risk factors associated with the spread of antibiotic-resistant bacteria in healthcare and community settings.
- To highlight the transmission routes and specific risk factors for key resistant pathogens.
- To discuss the implications of recent advancements in antibiotic development and the ongoing need for infection control.
Main Methods:
- Review and synthesis of existing literature on antibiotic resistance mechanisms and spread.
- Identification and categorization of risk factors for various antibiotic-resistant organisms.
- Analysis of transmission routes, including person-to-person contact, airborne transmission, and environmental contamination.
Main Results:
- Excessive antibiotic use is the primary driver of resistance.
- Overcrowding, poor hygiene, and inadequate infection control facilitate spread.
- Specific risk factors identified for MRSA, VRE, Gram-negative bacteria, penicillin-resistant pneumococci, and multidrug-resistant tuberculosis.
- Airborne transmission is a key route for penicillin-resistant pneumococci and multidrug-resistant tuberculosis.
Conclusions:
- Combating antibiotic resistance requires a multi-faceted approach, including rational antibiotic prescribing and stringent infection control practices.
- While new antibiotic development is promising, it will not eliminate the need for preventative measures.
- Minimizing the spread of antibiotic resistance is essential for preserving the efficacy of existing and future treatments.